tiprankstipranks
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
PremiumPress ReleasesAlvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
8d ago
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
PremiumPress Releases
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
8d ago
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
PremiumPress Releases
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
13d ago
Alvotech management to meet virtually with Northland
PremiumThe FlyAlvotech management to meet virtually with Northland
15d ago
Alvotech and Teva Announce U.S. FDA Approval  of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
PremiumPress Releases
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
16d ago
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
PremiumPress Releases
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
16d ago
Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024
PremiumPress ReleasesAlvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024
29d ago
Alvotech Announces Increase in Number of Own Shares
PremiumPress Releases
Alvotech Announces Increase in Number of Own Shares
1M ago
Alvotech Announces Increase in Number of Own Shares
PremiumPress Releases
Alvotech Announces Increase in Number of Own Shares
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100